A Google software engineer's LinkedIn post admitting to a lack of fundamental coding skills—including SQL, Git, and even ...
A software engineer at Google sparked an online debate after admitting he doesn’t understand fundamental coding concepts ...
NVIDIA's continued investment in Recursion Pharmaceuticals strengthens the view that Recursion is a favored investment within ...
Recursion CEO Chris Gibson defends the NIH, investing $1 million into a pre-seed venture to encourage critical research and ...
Plus: A shift in bird flu strategy, a new vaccine for meningococcal disease, a new AI genomics model from Nvidia and more.
The cuts hit the FDA’s medical device center particularly hard, impacting product reviewers and researchers of AI-enabled ...
Salt Lake City-based accelerator Altitude Lab is hoping it can entice biotechs impacted by the uncertainty surrounding federal grants.
This little-known artificial intelligence growth stock is backed by chipmaker Nvidia and recently jumped nearly 24% in a ...
Chris Gibson, Recursion’s head, cited the role small business grants played in helping Recursion grow its business.
If policymakers fail to act swiftly to restore medical research funding, then it’s up to those of us in the industry with the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results